ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IIA HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IIA HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IIA HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
PET scans guide new drug combo in fight against early Hodgkin's
Disease control OngoingThis study is testing a personalized treatment plan for adults with early-stage Hodgkin lymphoma. It uses a PET scan after initial chemotherapy to decide if patients need additional immunotherapy. The goal is to control the cancer effectively while aiming to reduce side effects c…
Matched conditions: ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo offers hope for older hodgkin lymphoma patients unsuitable for standard chemo
Disease control OngoingThis study is testing a combination of two immunotherapy drugs, nivolumab and brentuximab vedotin, for older adults or those who cannot tolerate standard chemotherapy for untreated Hodgkin lymphoma. The goal is to see how well this drug combination controls the cancer by helping …
Matched conditions: ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC